Healthpeak Properties Inc (DOC)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $13.23B
Last updated: Nov 17, 2026 at 11:04 AM ET
Healthpeak Properties Inc (DOC) Stock Forecast
Healthpeak Properties (DOC) has an FFO per share estimate of $1.78 for 2026. Analysts expect EPS of $0.09 for the fiscal year ending Dec 31, 2026, on revenue of $2.94B. Of 22 analysts, 8 rate the stock Buy or Strong Buy, 14 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 22 ratings average 2.50, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 36% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 13.6% |
| Buy | 5 | 22.7% |
| Hold | 14 | 63.6% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 22
Price Target
Analyst price targets are part of paid GNG plans. See plans
FFO Estimates
FFO per share is expected at $1.78 for 2026, up 0.6% from $1.77 in 2025, and at $1.85 for 2027, up 3.9%.
- FFO per share, 2026
- $1.78
- Estimate
- FFO per share, 2027
- $1.85
- Estimate
- Fiscal year ending Dec 31, 2026
- $0.09
- EPS consensus, revenue $2.94B
- Next report
- Feb 1, 2027
- Estimated
| Fiscal year | Basis | FFO per share | Change |
|---|---|---|---|
| 2025 | Actual | $1.77 | N/A |
| 2026 | Estimate | $1.78 | +0.6% |
| 2027 | Estimate | $1.85 | +3.9% |
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 55.6% and revenue estimates rise 7.1%.
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.09 | $0.09 to $0.09 | 1 | $2.94B | $2.53B to $3.06B | 11 |
| Dec 31, 2027 | $0.14 | $0.12 to $0.16 | 2 | $3.15B | $2.85B to $3.45B | 10 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.04 | $0.02 to $0.08 | 6 | $778.90M | $676.59M to $887.04M | 12 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 40.0% from $0.15.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.09 | N/A | N/A | N/A | $0.15 | -40.0% |
| Fiscal year ending Dec 31, 2027 | $0.14 | $0.14 | -$0.15 | -$0.15 | $0.15 | -6.7% |
Frequently Asked Questions About DOC
What is the DOC stock forecast?
Healthpeak Properties's FFO per share estimate for 2026 is $1.78. Consensus analyst estimates put Healthpeak Properties's EPS at $0.09 for the fiscal year ending Dec 31, 2026, on revenue of $2.94B. The consensus rating from 22 analysts is Hold.
How do analysts rate DOC stock?
Of 22 analysts covering Healthpeak Properties, 3 rate it Strong Buy, 5 Buy, 14 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from DOC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.09, with estimates from $0.09 to $0.09 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.14, with estimates from $0.12 to $0.16 from 2 analysts.
What revenue do analysts expect from Healthpeak Properties next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.94B, with estimates from $2.53B to $3.06B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.15B, with estimates from $2.85B to $3.45B.
How many analysts cover DOC?
22 analysts rate Healthpeak Properties stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
DOC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors